Beta Trials Platform | The Solution for Biotechs

Learn about our exclusive platform that allows biotechs to launch their clinical trials without an IND, with valid data for FDA submission and for a fraction of the cost compared to U.S. prices.

In this slide deck you will learn:

  • The advantages of conducting Phase I Trials outside the U.S.

  • Clinical Research Comparison between Mexico and Australia

  • How to submit trial data to the FDA without an IND

Watch the complete Webinar here:

Cohortias International